Heska to acquire MBio Diagnostics for $39m.

Heska, a provider of advanced veterinary diagnostic, to acquire MBio Diagnostics, a pioneer in innovative planar waveguide fluorescence immunoassay diagnostics, for $39m. "We are thrilled to welcome the entire LightDeck team to Heska. We have known and closely followed their success for years and we are happy to fully join with them today as one team focused on supercharging their great work. LightDeck brings to Heska best-in-breed, highly scalable manufacturing and world-class assay development to help drive our strategies for winning at innovation and winning at scale," Kevin Wilson, Heska CEO and President.